Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05764_nanopub.RAU9vUY_SjmaJUrqmajnh4KUAQEABIctJ8WaCO5CXmZ1o#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05764 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05764 label "ABT-263 [drugbank:DB05764]" assertion.
- drugbank:DB05764 seeAlso DB05764 assertion.
- drugbank:DB05764 description "ABT-263 is an orally bioavailable small molecule inhibitor of Bcl-2 family proteins. It is a substance being studied in the treatment of lymphomas and other types of cancer. It blocks some of the enzymes that keep cancer cells from dying." assertion.
- drugbank:DB05764 identifier "drugbank:DB05764" assertion.
- drugbank:DB05764 title "ABT-263" assertion.
- drugbank:DB05764 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05764 drugbank_vocabulary:drugbank-id "DB05764" assertion.
- drugbank:DB05764 bio2rdf_vocabulary:x-identifiers.org DB05764 assertion.
- drugbank:DB05764 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05764" assertion.
- drugbank:DB05764 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05764 bio2rdf_vocabulary:identifier "DB05764" assertion.